SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Rage Against the Machine

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Thomas M.1/8/2022 10:10:11 PM
of 1296
 
Fluvoxamine is a VERY successful Covid treatment. This provides us a clear view of the poisonous effect of Big Pharma's tyranny. Everything is rigged, including scientific journals and public health bureaucracies.

  • Big Pharma wants the massive, steady revenue stream of mRNA vaccines
  • any effective treatment of Covid would discourage vaccine acceptance
  • hence, all treatments must be suppressed

  1. We’ve known it works since August 24, 2020. That is when the phase 2 results were published. Since FLV is a safe drug, it should have been widely discussed with patients that there is virtually no downside and a huge reduction in hospitalization if the drug is given early. Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. Once the Phase 2 result came out, it should have been embraced by doctors. The medical community did nothing (with a few exceptions like Dr. Seftel).

  2. The infectious disease scientists lied to me. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. That was a lie. Pretty much nothing changed when the Phase 3 trial confirmed fluvoxamine worked. . Fluvoxamine was reportedly added to just 2 practice guidelines. Medicine isn’t about saving lives anymore. Those days are gone.

  3. Government agencies are ignoring the science. NIH and WHO refuse to acknowledge it works since it will cause vaccine hesitancy if it is known that there is a drug that turns COVID into a mild disease. That’s why they didn’t change their recommendation when the Phase 3 trial was published in Lancet. I fully expected both organizations to do absolutely nothing. They knew in advance it was coming and on the day the paper was published they ignored it entirely.

  4. Lack of action. All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. All the medical journals refused to publish the meeting notes (rejected by 6 journals).


more details:

stevekirsch.substack.com

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext